Foldax Inc.

Foldax Inc.

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://www.foldax.com

Last Round

Series D

Jun 22, 2020

Total Funding Raised

$20M

Momentum Score

25 /100

Company Overview

Foldax Inc. is a medical device company focused on reinventing heart valves to create treatments that can last a lifetime. The company develops synthetic, biopolymer heart valves (the TRIA platform) designed to address the historical trade-offs between traditional tissue and mechanical valves. Its proprietary LifePolymer material is intended to be more durable and reduce the risk of calcification, potentially eliminating the need for lifelong anticoagulant medication for patients. Foldax utilizes robotic manufacturing to ensure precision, consistency, and quality, which also improves the economics of production. The company is conducting clinical trials for its aortic and mitral valves and has received approval for commercial use of its TRIA mitral valve in India.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Clinical Trials, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

polymer heart valveheart valve replacementLifePolymerMedTechtranscatheter heart valvesynthetic heart valveanticoagulant-free valverobotic manufacturingcardiac implantTAVRbiopolymersurgical heart valveclinical-stage medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Foldax Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Foldax Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJun 22, 2020
VC RoundDec 19, 2018
Series AAug 31, 2015

Foldax Inc. Investors

Notable investors and investment history

InvestorRounds
Summation Health VenturesVC Round
California Institute of TechnologySeries D, VC Round
Kairos VenturesSeries D, VC Round, Series A
BioStar CapitalSeries D, VC Round
MemorialCare Innovation FundSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 5, 2025

    Partnered with Dolphin Life Science LLP for India launch.

  • Sep 5, 2025

    The Tria polymer mitral valve was launched in India on September 5, 2025.

Foldax Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Foldax Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Foldax Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range46
Year Founded2013
Last FundingJun 22, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.